VYNE VYNE Therapeutics Inc.
$28.56▲ +0.00%
Healthcare
Other
Volume 93.3K
Avg Volume (10D) 47.3K
Key Metrics & Fundamentals
Market Cap
$19.07M
P/E Ratio
–
Div Yield
–%
52W Range
14.03 - 46.95
% vs 50 MA
-4.48%
% vs 200 MA
21.63%
RSI-14
34.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
-45.91
Free Cash Flow
-$4.08M
Gross Rev
$86,000
Gross Profit
$86,000
EBITDA
-$3.81M
COGS
–
Operating Exp
$3.90M
Operating Income
-$3.82M
EBIT
-$3.82M
Pretax Income
-$3.59M
Net Income
-$3.59M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
No recent news found for VYNE.
Financial Overview - Income Statement
Quarterly
Mar 2026
See VYNE's money flow as a full page
Social Sentiment
No Reddit posts found for VYNE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.